Review of magnesium and metabolic syndrome

New Perspectives in Magnesium Research: Nutrition and Health

Volumn , Issue , 2007, Pages 189-196

  Kumeda, Yasuro ^a   Inaba, Masaaki ^b  

^a Jyurakukai Ohno Memorial Hospita ^*  (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950206378     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-483-0_15     Document Type: Chapter

References (20)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607
2. Kaplan NM. The deadly quartet. Arch Int Med 1989;149:1514-1520
3. DeFronzo RA, Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
5. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787
6. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-213
7. Altura BM, Altura BT. Magnesium and cardiovascular biology: An important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 1995;41:347-359
8. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995;48:927-940
9. Legrand C, Okitolonda W, Pottier AM, et al. Glucose homeostasis in magnesiumdeficient rats. Metabolism 1987;36:160-164
10. Polisso G, Barbagallo M. Hypertension, diabetes mellitus and insulin resistance. The role of intracellular magnesium. Am J Hypertens 1997;10:346-355
11. McKeown NM. Whole grain intake and insulin sensitivity: Evidence from observational studies. Nutr Rev 2004;62:286-291
12. 2+ modulates membrane lipids in vascular smooth muscle: A link to atherogenesis. FEBS Lett 1997;408:191-194
13. Rayssiguier Y, Gueux E. Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 1986;5:507-519
14. Altura BT, Brust M, Bloom S, et al. Magnesium dietary intake modulates blood lipid levels and atherosclerosis. Proc Natl Acad Sci U S A 1990;87:1840-1844
15. Lal J, Vasudev K, Kela AK, et al. Effect of oral magnesium supplementation on the lipid profi le and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India 2003;51:37-42
16. Hsieh ST, Sano H, Saito K, et al. Magnesium supplementation prevents the development of alcohol-induced hypertension. Hypertension 1992;19:175-182
17. 2+ currents of capillary endothelial cells from rat brain. FEBS Lett 1996;394: 335-339
18. Paolisso G, Barbagallo M. Hypertensions, diabetes mellitus and insulin resistance. The role of intracellular magnesium. Am J Hypertens 1997;10:346-355
19. Shimosawa T, Takano K, Ando K, et al. Magnesium inhibits norepinephrine release by blocking N-Type calcium channels at peripheral sympathetic nerve endings. Hypertension 2004;44:897-902
20. Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175-1181.